NYSE:AVNSAvanos Medical Stock Price, Forecast & News

Avanos Medical's stock was trading at $29.01 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AVNS shares have increased by 2.9% and is now trading at $29.85. View which stocks have been most impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last year. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Avanos Medical.

Avanos Medical is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Avanos Medical.

Avanos Medical Inc (NYSE:AVNS) issued its quarterly earnings data on Wednesday, May, 6th. The company reported $0.16 earnings per share for the quarter, meeting analysts' consensus estimates of $0.16. The firm had revenue of $180.40 million for the quarter, compared to the consensus estimate of $175.15 million. Avanos Medical had a positive return on equity of 4.09% and a negative net margin of 3.07%. The business's quarterly revenue was up 9.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.15 EPS. View Avanos Medical's earnings history.

7 analysts have issued twelve-month price targets for Avanos Medical's shares. Their forecasts range from $30.00 to $48.00. On average, they expect Avanos Medical's share price to reach $36.00 in the next year. This suggests a possible upside of 20.6% from the stock's current price. View analysts' price targets for Avanos Medical.

Media coverage about AVNS stock has been trending neutral recently, InfoTrie reports. The research group identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Avanos Medical earned a news sentiment score of 0.5 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news about Avanos Medical.

Avanos Medical saw a decline in short interest in the month of June. As of June 15th, there was short interest totaling 2,370,000 shares, a decline of 13.8% from the May 31st total of 2,750,000 shares. Based on an average daily trading volume, of 430,000 shares, the short-interest ratio is presently 5.5 days. Currently, 5.1% of the shares of the company are short sold. View Avanos Medical's Current Options Chain.

Some companies that are related to Avanos Medical include MSA Safety (MSA), Wound Management Technologies (WNDM), Wright Medical Group (WMGI), Inogen (INGN), Establishment Labs (ESTA), RTI Surgical (RTIX), Invacare (IVC), Sientra (SIEN), Lakeland Industries (LAKE), ConforMIS (CFMS), COLLPLANT HOLDI/S (CLGN), Allied Healthcare Products (AHPI), Histogenics (HSGX), Precision Therapeutics (POAI) and Rewalk Robotics (RWLK). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly Clark (KMB), AT&T (T), Alibaba Group (BABA), CVS Health (CVS), Honeywell International (HON), Procter & Gamble (PG), Verizon Communications (VZ), Home Depot (HD), Johnson & Johnson (JNJ) and Altria Group (MO).

Avanos Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVNS."

Avanos Medical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Confluence Investment Management LLC (1.16%) and Diversified Trust Co (0.03%). Company insiders that own Avanos Medical stock include Gary Blackford, John W Wesley, Joseph Fralin Woody and Steven E Voskuil. View institutional ownership trends for Avanos Medical.

AVNS stock was sold by a variety of institutional investors in the last quarter, including Confluence Investment Management LLC. View insider buying and selling activity for Avanos Medical.

AVNS stock was acquired by a variety of institutional investors in the last quarter, including Diversified Trust Co. Company insiders that have bought Avanos Medical stock in the last two years include Gary Blackford, John W Wesley, Joseph Fralin Woody, and Steven E Voskuil. View insider buying and selling activity for Avanos Medical.

Shares of AVNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of AVNS stock can currently be purchased for approximately $29.85.

Avanos Medical has a market capitalization of $1.43 billion and generates $697.60 million in revenue each year. The company earns $-45,900,000.00 in net income (profit) each year or $1.07 on an earnings per share basis. Avanos Medical employs 4,700 workers across the globe.

The official website for Avanos Medical is avanos.com.

Avanos Medical's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The company can be reached via phone at 844-428-2667 or via email at [email protected]